The Synthetic Cannabinoids
Eurasian Journal of Toxicology April 30, 2024 DOI: 10.51262/ejtox.1463809 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | The authors state that recreational use of synthetic cannabinoids increased more than that of other psychoactive substances in Europe and the United States over the last decade, driven by stronger effects than cannabis, affordability, easy accessibility, and freedom from standard drug testing. The article reviews their structure, toxicology, diagnosis, and treatment. |
Abstract
Synthetic cannabinoids are defined as psychoactive substances that trigger the endocannabinoid system. They are largely used as narcotics, although some of their effects are used for therapeutic purposes. In the last decade, recreational use in Europe and the United States has increased more than other psychoactive substances. In Turkey it is called "Bonzai" or "Jamaica". In addition, a stronger effect than cannabis, affordability, easy accessibility and freedom from standard drug testing contribute to the increasing use of synthetic cannabinoids. In this article, we will examine the structure and toxicology of synthetic cannabinoids and review the diagnosis and treatment of synthetic cannabinoids in the light of current literature.